tiprankstipranks
Aprea Therapeutics Inc (APRE)
NASDAQ:APRE
US Market
Holding APRE?
Track your performance easily

Aprea Therapeutics (APRE) Financial Statements

445 Followers

Aprea Therapeutics Financial Overview

Aprea Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.812; its P/E ratio is -1.07; Aprea Therapeutics is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.66. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 354.62K$ 561.57K$ 380.57K$ 583.23K-
Gross Profit$ 354.62K$ 561.57K$ 380.57K$ 263.76K$ 319.47K
EBIT$ -3.78M$ -3.47M$ -2.81M$ -3.67M$ -3.52M
EBITDA$ -3.78M$ -3.46M$ -2.80M$ -3.67M$ -3.52M
Net Income Common Stockholders$ -3.78M$ -3.47M$ -2.81M$ -3.44M$ -3.20M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 26.25M$ 28.69M$ 32.37M$ 21.61M$ 25.35M
Total Assets$ 26.89M$ 29.96M$ 33.20M$ 22.65M$ 25.77M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -26.25M$ -28.69M$ -32.37M$ -21.61M$ -25.35M
Total Liabilities$ 4.95M$ 4.41M$ 4.28M$ 5.70M$ 5.48M
Stockholders Equity$ 21.95M$ 25.56M$ 28.92M$ 16.95M$ 20.29M
Cash Flow-
Free Cash Flow$ -2.47M$ -3.65M$ -3.94M$ -3.75M$ -2.33M
Operating Cash Flow$ -2.47M$ -3.64M$ -3.94M$ -3.74M$ -2.24M
Investing Cash Flow-$ -7.50K$ -7.98K$ -7.15K$ -85.94K
Financing Cash Flow$ -1.16K$ -21.06K$ 14.71M--
Currency in USD

Aprea Therapeutics Earnings and Revenue History

Aprea Therapeutics Debt to Assets

Aprea Therapeutics Cash Flow

Aprea Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis